Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis
Authors
Keywords
-
Journal
Oncogenesis
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-15
DOI
10.1038/s41389-020-00297-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis
- (2019) Alaa Moamer et al. EBioMedicine
- Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion
- (2019) Ana Lluch et al. EUROPEAN JOURNAL OF CANCER
- Prolactin hormone exerts anti-tumorigenic effects in HER-2 overexpressing breast cancer cells through regulation of stemness
- (2019) Ibrahim Y. Hachim et al. Stem Cell Research
- Re-Evaluating E-Cadherin and β-Catenin
- (2018) Nicholas Borcherding et al. AMERICAN JOURNAL OF PATHOLOGY
- Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
- (2018) Piyush B. Gupta et al. Cell Stem Cell
- A framework for the development of effective anti-metastatic agents
- (2018) Robin L. Anderson et al. Nature Reviews Clinical Oncology
- A 100-Year Review: Mammary development and lactation
- (2017) R. Michael Akers JOURNAL OF DAIRY SCIENCE
- The global burden of women’s cancers: a grand challenge in global health
- (2017) Ophira Ginsburg et al. LANCET
- Exclusion of Kaposi Sarcoma From Analysis of Cancer Burden—Reply
- (2017) Christina Fitzmaurice et al. JAMA Oncology
- A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome
- (2016) Ibrahim Y. Hachim et al. HUMAN PATHOLOGY
- RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation
- (2016) Robert A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer
- (2016) Neeraj Agarwal et al. ONCOLOGIST
- Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer
- (2016) Ciara C. O’Sullivan et al. ONCOLOGIST
- Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy
- (2016) Vanessa M. López-Ozuna et al. Scientific Reports
- Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer
- (2016) Ibrahim Y. Hachim et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Mechanisms of lapatinib resistance in HER2-driven breast cancer
- (2015) Valentina D’Amato et al. CANCER TREATMENT REVIEWS
- Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors
- (2015) Mauricio Rodriguez-Torres et al. CLINICAL & EXPERIMENTAL METASTASIS
- Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study
- (2015) Rumiko Tashima et al. PLoS One
- A role for E-cadherin in ensuring cohesive migration of a heterogeneous population of non-epithelial cells
- (2015) Kyra Campbell et al. Nature Communications
- Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
- (2014) Nicola Aceto et al. CELL
- Improved vectors and genome-wide libraries for CRISPR screening
- (2014) Neville E Sanjana et al. NATURE METHODS
- Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer
- (2013) Antoinette Hollestelle et al. BREAST CANCER RESEARCH AND TREATMENT
- Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer
- (2013) Louise Maymann Nitze et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Prolactin Receptor Expression and Breast Cancer: Relationships with Tumor Characteristics among Pre- and Post-menopausal Women in a Population-Based Case–Control Study from Poland
- (2013) Jessica M. Faupel-Badger et al. Hormones & Cancer
- Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
- (2012) S. Guiu et al. ANNALS OF ONCOLOGY
- Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
- (2011) Alysha K. Croker et al. BREAST CANCER RESEARCH AND TREATMENT
- Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
- (2010) Andrey I. Khramtsov et al. AMERICAN JOURNAL OF PATHOLOGY
- Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
- (2010) Salvatore Pece et al. CELL
- BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells
- (2010) Gemma Molyneux et al. Cell Stem Cell
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- Breast Cancer Stem Cells: Eradication by Differentiation Therapy?
- (2009) Hartmut Beug CELL
- Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
- (2009) E. Charafe-Jauffret et al. CLINICAL CANCER RESEARCH
- Re-evaluation of the prolactin receptor expression in human breast cancer
- (2009) Elisabeth Douglas Galsgaard et al. JOURNAL OF ENDOCRINOLOGY
- Complex prolactin crosstalk in breast cancer: New therapeutic implications
- (2009) Kristopher C. Carver et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Mammary development meets cancer genomics
- (2009) Aleix Prat et al. NATURE MEDICINE
- HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
- (2008) H Korkaya et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search